" class="no-js "lang="en-US"> Robert W. Keane - Medtech Alert
Friday, December 01, 2023
Robert W. Keane

Robert W. Keane

About Robert W. Keane

Related Story

ZyVersa Therapeutics and University of Miami Awarded a Grant From the Michael J. Fox Foundation to Determine if Inhibition of Microglial Inflammasome Activation With IC100 Blocks Neuroinflammation Driving Parkinson's Disease Pathology

July 28 2022

ZyVersa Therapeutics, Inc. (ZyVersa), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for treatment of […]